Items where Author is "Ilg, Marcus M."

Journal Article

Ilg, Marcus M. ORCID: https://orcid.org/0000-0003-0803-0610, Ralph, David J. and Cellek, Selim ORCID: https://orcid.org/0000-0002-4856-285X (2023) Statins synergize with phosphodiesterase type 5 inhibitors but not with selective estrogen receptor modulators to prevent myofibroblast transformation in an in vitro model of Peyronie’s disease. Journal of Sexual Medicine. ISSN 1743-6109 (Accepted)

Gullberg, Donald, Ilg, Marcus M. ORCID: https://orcid.org/0000-0003-0803-0610, Lapthorn, Alice, Ralph, David J. and Cellek, Selim ORCID: https://orcid.org/0000-0002-4856-285X (2022) Phenotypic screening of 1,953 FDA-approved drugs reveals 26 hits with potential for repurposing for Peyronie’s disease. PLOS ONE, 17 (12). e0277646. ISSN 1932-6203

Lapthorn, Alice, Ilg, Marcus M. ORCID: https://orcid.org/0000-0003-0803-0610, Sullivan, Justine, Dziewulski, Peter and Cellek, Selim ORCID: https://orcid.org/0000-0002-4856-285X (2022) Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars. European Journal of Pharmacology, 937. p. 175374. ISSN 0014-2999

Ilg, Marcus M., Stafford, Simon J., Mateus, Marta, Bustin, Stephen A., Carpenter, Michael J., Muneer, Asif, Bivalacqua, Trinity J., Ralph, David J. and Cellek, Selim (2020) Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's Disease. Journal of Sexual Medicine, 17 (10). pp. 1848-1864. ISSN 1743-6109

Weyne, Emmanuel, Ilg, Marcus M., Cakir, Onur Omer, Muneer, Asif, Roussel, Delphine Behr, Albersen, Maarten, Angulo, Javier, Corona, Giovanni, Bettocchi, Carlo, Reisman, Yacov and Castiglione, Fabio (2020) European Society for Sexual Medicine Consensus Statement on the Use of the Cavernous Nerve Injury Rodent Model to Study Postradical Prostatectomy Erectile Dysfunction. Sexual Medicine, 8 (3). pp. 327-337. ISSN 2050-1161

Ilg, Marcus M. ORCID: https://orcid.org/0000-0003-0803-0610 and Cellek, Selim ORCID: https://orcid.org/0000-0002-4856-285X (2020) Unwinding Fibrosis in Peyronie's Disease. Journal of Sexual Medicine, 17 (5). pp. 838-840. ISSN 1743-6109

Milenkovic, Uros, Ilg, Marcus M., Cellek, Selim and Albersen, Maarten (2019) Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie’s Disease. Sexual Medicine Reviews, 7 (4). pp. 679-689. ISSN 2050-0521

Milenkovic, Uros, Ilg, Marcus M., Zuccato, Carola, Ramazani, Yasaman, De Ridder, Dirk and Albersen, Maarten (2019) Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie's disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation. BJU International, 123 (4). pp. 703-715. ISSN 1464-410X

Milenkovic, Uros, Ilg, Marcus M., Cellek, Selim and Albersen, Maarten (2019) What role do pharmaceuticals play in the treatment of Peyronie’s disease and is there a need for new emerging drugs? Expert Opinion on Emerging Drugs, 24 (1). pp. 1-4. ISSN 1472-8214

Ilg, Marcus M., Mateus, Marta, Stebbeds, William J., Milenkovic, Uros, Christopher, Nim, Muneer, Asif, Albersen, Maarten, Ralph, David J. and Cellek, Selim (2019) Antifibrotic synergy between phosphodiesterase type 5 inhibitors and selective oestrogen receptor modulators in Peyronie’s disease models. European Urology, 75 (2). pp. 329-340. ISSN 1873-7560

Mateus, Marta, Ilg, Marcus M., Stebbeds, William J., Christopher, Nim, Muneer, Asif, Ralph, David J and Cellek, Selim (2018) Understanding the role of adenosine receptors in the myofibroblast transformation in Peyronie’s disease. Journal of Sexual Medicine, 15 (7). pp. 947-957. ISSN 1743-6109

Thesis

Ilg, Marcus M. ORCID: https://orcid.org/0000-0003-0803-0610 (2019) Investigating the effect of phosphodiesterase type 5 inhibitors and selective oestrogen receptor modulators in models of Peyronie's disease. Doctoral thesis, Anglia Ruskin University.